ASCO AIA

Advocacy In Action: Palliative Care Is Not Just End Of Life Care
Jul
11
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Palliative Care In this segment, the panel discusses the many facets of palliative care and how it is not just for end of life stages, but all stages of treatment and has many faces. Joining Selma Schimmel as co-moderators are: Jamie […]

Read More
Advocacy In Action: Palliative Care Is Quality Of Life Care
Jul
11
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Palliative Care In this segment, the panel discusses the quality of life aspects of palliative care. Joining Selma Schimmel as co-moderators are: Jamie H. Von Roenn, MD – Professor of Medicine, Division of Hematology/Oncology; Feinberg School of Medicine, Northwestern University; Robert […]

Read More
Advocacy In Action: Access To Palliative Care
Jul
11
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Palliative Care In this segment, the panel discusses how patients gain access to palliative care, the barriers and how we need to teach patients the questions to ask and the services available to help them through all facets of their cancer […]

Read More
Advocacy In Action: The Face Of Palliative Care
Jul
11
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Palliative Care In this segment, host, Selma Schimmel, reveals herself as the face of palliative care, sparking the conversation that it is not just for end of life, but at all stages of treatment to enhance quality of life. Joining Selma […]

Read More
Advocacy In Action: Lung Cancer Treatment Guidelines and Molecular Testing
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. Joining Selma Schimmel as co-moderators are: David R. Spigel, MD – Director, Lung Cancer Research Program at Sarah Cannon Research Institute and a Medical Oncologist at Tennessee Oncology, PLLC, Nashville, TN Ming S. Tsao, […]

Read More
Advocacy In Action: Palliative Care
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Palliative Care In this segment, the panel discusses the quality of life aspects of palliative care. Joining Selma Schimmel as co-moderators are: Jamie H. Von Roenn, MD – Professor of Medicine, Division of Hematology/Oncology; Feinberg School of Medicine, Northwestern University; Robert […]

Read More
Advocacy In Action: What If a Patient Is Told They Have No Tumor Marker?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  What if a patient tests negative for molecular testing and has no tumor marker?  How do you explain to them that this is still personalized medicine? Joining Selma Schimmel […]

Read More
Advocacy In Action: What If Molecular Testing Is Not Offered?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  If my doctor does not recommend that I have my tumor tested, how do I insist on it and where should I go? Joining Selma Schimmel as co-moderators are: […]

Read More
Advocacy In Action: What Should Patients Expect When Getting Molecular Testing?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  When a patient is told they need to have their tumor tested, what should they expect? Joining Selma Schimmel as co-moderators are: David R. Spigel, MD – Director, Lung […]

Read More
Advocacy In Action: Who Should Have Molecular Testing When Diagnosed With Lung Cancer?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  Why are only EFR and ALK are tested for and who should be tested? Joining Selma Schimmel as co-moderators are: David R. Spigel, MD – Director, Lung Cancer Research […]

Read More